China biotech industry gets talent injection

A shift from copycat drugs to a research-driven biotech industry is attracting expat scientists back home to help meet the challenges of an ageing population.

When Dr Yang Dajun who is working on curing diseases related to aging, chose to return to China in 2005 to launch his own biopharmaceutical start-up after almost two decades in the US, he said the decision wasn’t easy.

“It was a bit difficult as at that time China’s biotech industry was at a very early stage. A lot of things were not available, especially the financial environment. But I’m not regretting the decision,”...

FinanceAsia has updated its subscription model. Registered readers now have the opportunity to read five articles from our award-winning website for free. Please subscribe for unlimited access.